Scarica l'app Stockscreener
5.9446
2.45%
-0.1654
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
Psyence Biomedical Ltd. Common Shares (PBM) Live Share Price, Invest From India - INDmoney
PBM Forecast, Price Target & Analyst Ratings | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Psyence Biomedical shares rise following equity investment agreement - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Why is Psyence Biomedical stock falling Wednesday? - MSN
Trending Stocks Today | Psyence Biomedical Soars 130.26% Pre-Market - Moomoo
Psyence Biomedical doses first patient in psilocybin cancer trial By Investing.com - Investing.com Australia
PBM jumps on Trump psychedelic push, ibogaine supply story - MSN
Psyence BioMed Begins Phase IIb Dosing of Psilocybin Candidate NPX-5 in Australian Cancer Adjustment Disorder Trial - TipRanks
Psyence BioMed (Nasdaq: PBM) doses first patient in NPX-5 Phase IIb trial - Stock Titan
Why Is Psyence Biomedical Stock Falling Wednesday? - Sahm
Psyence Biomedical doses first patient in psilocybin cancer trial - Investing.com
Psyence Biomedical (PBM) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder - The Manila Times
Psyence Biomedical Ltd. Begins Phase IIb Clinical Trial for NPX-5 Psilocybin Treatment in Cancer Patients - Quiver Quantitative
PBMWW Psyence highlights clinical trial progress as core strategic priority in its latest quarterly earnings release.Community Watchlist - Cổng thông tin điện tử Tỉnh Sơn La
Why is Psyence Biomedical stock trading lower on Tuesday? - MSN
Psyence Biomedical Ltd.Common Shares (NQ:PBM) - FinancialContent
Psyence Biomedical Ltd - Reuters
Psyence Biomedical Tumbles On Heels Of Trump Executive OrderPsyence Biomedical (NASDAQ:PBM) - Benzinga
$Psyence Biomedical (PBM.US)$ hope i timed a good entry on this one - Moomoo
Psyence Biomedical Adds Intraday Equity Purchase Option in White Lion Financing Deal - The Globe and Mail
Is Psyence (PBM) stock a suitable buy candidate (Soars) 2026-04-20Certified Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Top Small Cap Stocks To Keep An Eye OnApril 20th - MarketBeat
What's going on in today's session - ChartMill
Psyence (PBMWW) Stock: Support and Resistance (Technical Strength) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story - Benzinga
These stocks are gapping in today's session - ChartMill
Psyence Biomedical provides update on position in global ibogaine market - TipRanks
$Psyence Biomedical (PBM.US)$ I'm definitely out now. Had to go for one last dip of the Honey pot.🍯 - Moomoo
Top movers in Monday's pre-market session - ChartMill
Morning Market Movers: ENVB, PBM, PASG, ATAI See Big Swings - RTTNews
Psyence Biomedical (PBM) adds intraday stock sale option with White Lion - Stock Titan
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - The Manila Times
Psyence Biomedical Ltd. Advances Strategic Position in Growing Ibogaine Market with Integrated GMP Manufacturing Platform - Quiver Quantitative
Psyence BioMed Positioned as World's Only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - 富途牛牛
$Psyence Biomedical (PBM.US)$ - Moomoo
$Psyence Biomedical (PBM.US)$ missed d opening over my toilet break😅 - Moomoo
Psyence Biomedical (PSYB) Stock: Gains Momentum as GMP Ibogaine Supply Strategy Draws Attention - parameter.io
EO Momo: Why Psychedelics Are in Play - StocksToTrade
Don’t Buy Any of these‼️ Unless you like Cashflow 😏 - Moomoo
Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test - TechStock²
Psyence BioMed Backs Prospective U.S. Ibogaine Review, Citing GMP Supply Leadership - The Globe and Mail
PBM Surges As Psyence Biomedical Rides Ibogaine Policy Wave - timothysykes.com
Trump Trade: President to sign order on psychedelic used for PTSD - Yahoo Finance
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):